dihexa pnb-0408 c-met hgfr activator Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib Drug development of MET inhibitors:
Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC dihexa pnb 0408 c met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa (PNB 0408) c Met HGFR Activator
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




